M. Picciafuoco

Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales.

A. Favero, M. Tonato, M. Sassi, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive Factors of Delayed Emesis in Cisplatin‐Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or Dexamethasone: A Randomized Single‐Blind Study

M. Tonato, F. Roila, S. Bracarda, 1991, American journal of clinical oncology.

Delayed emesis induced by moderately emetogenic chemotherapy: do we need to treat all patients? The Italian Group for Antiemetic Research.

A. Favero, C. Boni, M. Tonato, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.

F. di Costanzo, M. Tonato, F. Roila, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reliability and validity of a quality of life questionnaire in cancer patients.

L. Crinò, M. Tonato, M. Soldani, 1993, European journal of cancer.

Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis

A. Favero, R. Garbelli, M. Tonato, 1992 .

Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.

M. Tonato, M. Sassi, F. Roila, 1991, European journal of cancer.

A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin

A. Favero, M. Tonato, F. Roila, 2008, Cancer Chemotherapy and Pharmacology.